AlloHeme

· CareDx, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AlloHeme, covering 2026-03-18 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme Test